GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Κατάταξη σε μετοχές
#3631
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Τιμή μετοχής
$27.54
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$4.67B
Αλλαγή (1 ημέρα)
-2.73%
Αλλαγή (1 έτος)
-11.86%
Χώρα
IN
Εμπόριο GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Κατηγορία
Healthcare
EPS για GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
EPS στις June 2026 TTM: $0.70
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της GlaxoSmithKline Pharmaceuticals Limited, το τρέχον EPS της εταιρείας (TTM) είναι $0.70. Στο τέλος του 2024, η εταιρεία είχε EPS $0.42, μείωση σε σύγκριση με το EPS του 2023 που ήταν $0.44.
Ιστορικό EPS της GlaxoSmithKline Pharmaceuticals Limited από 2004 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.70 | 8.72% |
| 2025 | $0.64 | 53.29% |
| 2024 | $0.42 | -4.31% |
| 2023 | $0.44 | 55.78% |
| 2022 | $0.28 | 20.93% |
| 2021 | $0.23 | 217.40% |
| 2020 | $0.07 | -80.72% |
| 2019 | $0.38 | 19.09% |
| 2018 | $0.32 | 3.69% |
| 2017 | $0.31 | -8.50% |
| 2016 | $0.34 | -7.07% |
| 2015 | $0.36 | -0.91% |
| 2013 | $0.36 | -39.74% |
| 2012 | $0.60 | 26.71% |
| 2011 | $0.48 | -35.63% |
| 2010 | $0.74 | 14.81% |
| 2009 | $0.64 | -10.33% |
| 2008 | $0.72 | -12.43% |
| 2007 | $0.82 | 11.92% |
| 2006 | $0.73 | 11.91% |
| 2005 | $0.66 | 47.32% |
| 2004 | $0.45 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| $29.89 | 4,195.77% |
US
|
|
| $6.60 | 848.55% |
US
|
|
| $3.55 | 410.20% |
US
|
|
| $1.26 | 81.09% |
US
|
|
| $20.39 | 2,830.30% |
CH
|
